Logistical Hurdles Leave COVID-19 Test Kits Unused

Scientists at academic labs equipped to test for SARS-CoV-2 report that multiple barriers are preventing from them from operating at full capacity.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, ANYAIVANOVA

University labs in the US that have been certified to test for the coronavirus and are ready to collaborate with clinics and hospitals are facing regulatory and logistical obstacles to distributing their tests, reports Nature. As a result, some labs are operating at half capacity or less, despite the demands for COVID-19 tests.

Human geneticist Stacey Gabriel of the Broad Institute of MIT and Harvard says that her lab could be analyzing 2,000 tests per day. “But we aren’t doing that many,” she tells Nature. “Yesterday was around 1,000. What is holding us back? That is the question.”

Several academic laboratories, including the Broad Institute, have invested in adapting their facilities so that they can use PCR to test for SARS-CoV-2, rapidly changing their scientific protocols and meeting federal regulations, as it became clear in late February that tests issued by the US Centers for Disease ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Amy Schleunes

    A former intern at The Scientist, Amy studied neurobiology at Cornell University and later earned her MFA in creative writing from the University of Iowa. She is a Los Angeles–based writer, editor, and communications strategist who collaborates on nonfiction books for Harper Collins and Houghton Mifflin Harcourt, and also teaches writing at Johns Hopkins University CTY. Her favorite projects involve sharing the insights of science and medicine.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo